ESSA Pharma Inc. (EPIX) has a consensus analyst rating of Hold, based on 5 analysts covering the stock. Of those, 2 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for EPIX is $9.50, representing a +4,621.7% upside from the current price of $0.2012. Price targets range from a low of $2.00 to a high of $17.00.